Skip to main content

Table 2 Characteristics of the study population at baseline [n (%)]

From: Study on predictive models for swallowing risk in patients with AECOPD

Index

WST ≤ 1

N = 50

WST ≥ 2

N = 50

p-value

Gender

   

 Male

40 (80%)

40 (80%)

1.000

 Female

10 (20%)

10 (20%)

1.000

Age

72.5 (65, 77)

79(76.25, 83)

< 0.001

Hospitalization days

6(6, 8)

8(6.25, 12.50)

0.003

Gastric tube

3(6%)

0(0%)

0.241

Course of disease(year)

8.5 (4, 10)

10 (7.25, 15)

0.066

Frequency of attacks

2(1, 2)

2(2, 3)

0.010

mMRC

2 (1, 3)

3 (3, 4)

< 0.001

CAT

16.5 (11, 22)

21 (16.5, 25)

< 0.001

FEV1%

38.4% (32.11%, 52.35%)

35.15% (29.40%, 43.6%)

0.189

BIPAP

   

 Yes

7 (14%)

25 (50%)

< 0.001

 No

43 (86%)

25 (50%)

< 0.001

Smoke

   

 Yes

40 (80%)

40 (80%)

1.000

 No

10 (20%)

10 (20%)

1.000

Pneumonia

   

 Yes

18(36%)

25 (50%)

0.226

 No

32(64%)

25 (50%)

0.226

PFG

   

 I

2 (4%)

3 (6%)

1.000

 II

14 (28%)

9 (18%)

0.342

 III

23 (46%)

15 (30%)

0.149

 IV

11 (22%)

23 (46%)

0.020

Comorbidity

   

Hypertension

27(54%)

31(62%)

0.543

Diabetes

7(14%)

9(18%)

0.785

Coronary Atherosclerotic heart disease

1(2%)

3(6%)

0.610

Heart failure

3(6%)

9(18%)

0.124

Cardiac Dysrhythmia

0(0)

3(6%)

0.241

Reflux esophagitis

4(8%)

2(4%)

0.674

  1. P values for statistical differences between groups according to data characteristics were obtained using the Wilcoxon rank-sum test, Pearson’s chi-square test, or the continuously corrected chi-square test; WST = water swallow test; CAT = COPD Assessment Test; mMRC = modified Medical Research Council; PFG = Pulmonary function grading